Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery
NCT06736483Phase 2Recruiting
- Sponsor
- CHU Montpellier
- Start
- Feb 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Rescue analgesic up to 7 days. Started Feb 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06736483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06736483.